Khater M

ORCID: 0000-0002-8492-8206 · 1 paper in corpus
2022
Molecules (Basel, Switzerland) ·doi:10.3390/molecules27154757

Antiangiogenic agents attenuate tumours' growth and metastases and are therefore beneficial as an adjuvant or standalone cancer regimen. Drugs with dual antiproliferative and antiangiogenic activities can achieve anticancer efficacy and ove…